Your browser doesn't support javascript.
loading
Case fatality rates of COVID-19 during epidemic periods of variants of concern: A meta-analysis by continents.
Xia, Qianhang; Yang, Yujie; Wang, Fengling; Huang, Zhongyue; Qiu, Wuqi; Mao, Ayan.
Affiliation
  • Xia Q; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China.
  • Yang Y; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China.
  • Wang F; Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong China.
  • Huang Z; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China.
  • Qiu W; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China.
  • Mao A; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China. Electronic address: mao.ayan@imicams.ac.cn.
Int J Infect Dis ; 141: 106950, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38309460
ABSTRACT

OBJECTIVES:

To calculate the case fatality rates (CFR) of COVID-19 during epidemic periods of different variants of concern (VOC) by continents.

METHODS:

We systematically searched five authoritative databases (Web of Science, PubMed, Embase, Cochrane Library, and MedRxiv) for epidemiological studies on the CFR of COVID-19 published between January 1, 2020, and March 31, 2023. After identifying the epidemic trends of variants, we used a random-effects model to calculate the pooled CFRs during periods of different VOCs. This meta-analysis was conducted following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and registered with PROSPERO (CRD42023431572).

RESULTS:

There were variations in the CFRs among different variants of COVID-19 (Alpha 2.62%, Beta 4.19%, Gamma 3.60%, Delta 2.01%, Omicron 0.70%), and disparities in CFRs also existed among continents. On the whole, the CFRs of COVID-19 in Europe and Oceania were slightly lower than in other continents. There was a statistically significant association between the variant, HDI value, age distribution, coverage of full vaccination of cases, and the CFR.

CONCLUSIONS:

The CFRs of COVID-19 varied across the epidemic periods of different VOCs, and disparities existed among continents. The CFR value reflected combined effects of various factors within a certain context. Caution should be exercised when comparing CFRs due to disparities in testing capabilities and age distribution among countries, etc.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa / Oceania Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: China Country of publication: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa / Oceania Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: China Country of publication: Canadá